Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data.
Karras
Spiros
S
Department of Endocrinology, Diabetes and Metabolism, Panagia General Hospital, Thessaloniki, Greece. krassas@the.forthnet.gr
Tzotzas
Themistoklis
T
Kaltsas
Themistoklis
T
Krassas
Gerasimos E
GE
D000328:Adult; D013956:Antithyroid Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001942:Breast Feeding; D002231:Carbimazole / Q000009:adverse effects / Q000627:therapeutic use; D002657:Child Development / Q000187:drug effects / Q000502:physiology; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000378:metabolism*; D007223:Infant; D007774:Lactation; D008713:Methimazole / Q000009:adverse effects / Q000627:therapeutic use; D008895:Milk, Human / Q000737:chemistry; D009035:Mothers; D011441:Propylthiouracil / Q000009:adverse effects / Q000627:therapeutic use
D013956:Antithyroid Agents; D008713:Methimazole; D011441:Propylthiouracil; D002231:Carbimazole